Peritoneal dialysis-associated peritonitis: Difference between revisions
From IDWiki
No edit summary |
No edit summary |
||
| Line 3: | Line 3: | ||
===Microbiology=== |
===Microbiology=== |
||
*Gram-positive bacteria (45%) |
|||
*[[Coagulase-negative staphylococci]] |
**[[Coagulase-negative staphylococci]] |
||
*[[Staphylococcus aureus]] |
**[[Staphylococcus aureus]] |
||
*[[Streptococci]] |
|||
*[[ |
**[[Streptococci]] |
||
**[[Diphtheroids]] |
|||
*[[Gram-negative bacteria]], if underlying GI pathology |
*[[Gram-negative bacteria]] (15%), especially if underlying GI pathology |
||
*Mixed bacterial (1-2%) |
|||
*Fungal (1%), particularly [[Candida]] |
|||
*[[Tuberculosis]] (<1%) |
|||
===Pathophysiology=== |
===Pathophysiology=== |
||
| Line 20: | Line 24: | ||
*[[Peritonitis]], with diffuse abdominal pain and tenderness and cloudy or purulent dialysate |
*[[Peritonitis]], with diffuse abdominal pain and tenderness and cloudy or purulent dialysate |
||
*Often afebrile |
|||
*Typically no fever |
|||
*Dialysate may have elevated WBCs >100 cells/mcL with >50% neutrophils |
|||
== Diagnosis == |
|||
* Aspirate dialysate, then centrifuge and inoculate into blood culture bottles (for both aerobic and anaerobic organisms) |
|||
==Management== |
==Management== |
||
*Empiric treatment should cover [[coagulase-negative staphylococci]] and gram-negatives, so [[vancomycin]] plus [[ceftriaxone]] or [[ceftazidime]] would be reasonable |
|||
*Intraperitoneal antibiotics are preferred unless systemic infection or bacteremia |
*Intraperitoneal antibiotics are preferred unless systemic infection or bacteremia |
||
*May attempt to salvage the catheter, especially for less virulent organisms like [[coagulase-negative staphylococci]] |
|||
*Indications for catheter removal include |
|||
**Difficult-to-treat organisms ([[Candida]], [[Staphylococcus aureus]], resistant Gram-negatives like [[Pseudomonas]] or [[Stenotrophomonas]]) |
|||
**Bowel perforation |
|||
**Relapse with same organism within a month |
|||
**Clinical failure despite 5 days of appropriate antibiotics |
|||
**Exit site infection |
|||
*Duration 14 to 21 days, or 1 week after catheter removal |
*Duration 14 to 21 days, or 1 week after catheter removal |
||
== Further Reading == |
|||
* ISPD Peritonitis Recommendations: 2016 Update on Prevention and Treatment. ''Perit Dial Int''. 2016;36:481. doi: [https://doi.org/10.3747/pdi.2016.00078 10.3747/pdi.2016.00078] |
|||
[[Category:Infectious syndromes]] |
[[Category:Infectious syndromes]] |
||
Revision as of 14:57, 2 June 2021
Background
Microbiology
- Gram-positive bacteria (45%)
- Gram-negative bacteria (15%), especially if underlying GI pathology
- Mixed bacterial (1-2%)
- Fungal (1%), particularly Candida
- Tuberculosis (<1%)
Pathophysiology
- Acquired from catheter, exit site, dialysate fluid, or transmural migration
Epidemiology
- On average one episode per patient per year
Clinical Manifestations
- Peritonitis, with diffuse abdominal pain and tenderness and cloudy or purulent dialysate
- Often afebrile
- Dialysate may have elevated WBCs >100 cells/mcL with >50% neutrophils
Diagnosis
- Aspirate dialysate, then centrifuge and inoculate into blood culture bottles (for both aerobic and anaerobic organisms)
Management
- Empiric treatment should cover coagulase-negative staphylococci and gram-negatives, so vancomycin plus ceftriaxone or ceftazidime would be reasonable
- Intraperitoneal antibiotics are preferred unless systemic infection or bacteremia
- May attempt to salvage the catheter, especially for less virulent organisms like coagulase-negative staphylococci
- Indications for catheter removal include
- Difficult-to-treat organisms (Candida, Staphylococcus aureus, resistant Gram-negatives like Pseudomonas or Stenotrophomonas)
- Bowel perforation
- Relapse with same organism within a month
- Clinical failure despite 5 days of appropriate antibiotics
- Exit site infection
- Duration 14 to 21 days, or 1 week after catheter removal
Further Reading
- ISPD Peritonitis Recommendations: 2016 Update on Prevention and Treatment. Perit Dial Int. 2016;36:481. doi: 10.3747/pdi.2016.00078
